Collaboration and business

Besides stimulating and negotiating research collaborations, we support the creation of spin-off companies with technologies from Radboudumc by evaluating business plans, protecting IP rights, negotiating license agreements, searching for initial funding and initiating contact with candidate CEOs and other experts.

We recently strengthened our collaboration with Janssen Pharmaceutica NV, Janssen-Cilag B.V. and Janssen Vaccines & Prevention B.V  to bring high quality innovative academic research faster to the patient and we concluded a partnership with Viiv Healthcare for identification of novel targets in HIV.

Through its subsidiary UMC St. Radboud Holding, Radboudumc takes an interest in these spin-off companies and keeps track of their development. The Holding has 19 spin-off companies in which 153 FTE are employed, and in which to date EUR 44M has been invested.
Research Valorization Business Development

Collaboration and business

The Business Development team helps our researchers in collaborations with external parties, protecting and exploitation of inventions, negotiating deals and setting up companies.

read more

Contact us

Secretariat Business Development

(024) 361 89 34
contact

Business development experts